ARCHIVES

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

This article is from The Cancer Letter archive.

Vol. 36 No. 24 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

Modality Combo Decreases Prostate Cancer Recurrence

August 27, 2004

Four Patients In Tamoxifin Treatment Trial Had Died of Uterine Cancer Prior To BCPT

April 29, 1994

DCPC Suggest Options For Encouraging New Minority Centers

May 4, 1984

Health Care Reform: Fundamental changes Ahead For Cancer Research And Care

October 8, 1993

Two Groups Take Different Approaches To Managing Toxicity Of Saltz Regimen.

June 22, 2001

Mammography Debate “Confused a Whole Generation” – Shalala

January 7, 1994